A pharmacist and biostatistician from The University of Western Australia has received Federal funding to reduce medicine-related harm while balancing symptom control for older adults.
Dr Amy Page, from UWA's School of Allied Health, has been awarded $1.98 million from the Medical Research Future Fund for early to mid-career researchers made possible by a $1 million grant provided by the Future Health Research and Innovation Fund.
Dr Page will use the grant to initiate reviews to optimise medication regimens to align with older adults' priorities and individualised treatment goals.
"Our team's research vision is for a healthcare system where reducing medicine's burden becomes routine care for older adults," Dr Page said.
"We will investigate a pathway to empower people to improve their quality of life through better management of their medications and ensuring the best possible outcomes."
Dr Page has been involved in investigating strategies in hospitals, general practice, community and aged care facilities to optimise medicine use.
"We're also looking at interventions to be able to improve medication treatment and optimal prescribing and it's very important these are happening in every setting."
The support of $1 million from the State Government's Future Health Research and Innovation Fund Major Research Application Support program helped Dr Page secure the Federal Government Medical Research Future Fund grant.
Dr Page has also secured further funding of over $7.5 million in-kind support for the project.
In 2024, Dr Amy Page was recognised with the Pharmaceutical Society of Australia's Pharmacist of the Year award.
